These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21190566)

  • 1. Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model.
    García S; Forteza J; López-Otin C; Gómez-Reino JJ; González A; Conde C
    Arthritis Res Ther; 2010; 12(6):R224. PubMed ID: 21190566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagenase-3 (MMP-13) deficiency protects C57BL/6 mice from antibody-induced arthritis.
    Singh A; Rajasekaran N; Hartenstein B; Szabowski S; Gajda M; Angel P; Bräuer R; Illges H
    Arthritis Res Ther; 2013; 15(6):R222. PubMed ID: 24369907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis.
    Jacobs JP; Pettit AR; Shinohara ML; Jansson M; Cantor H; Gravallese EM; Mathis D; Benoist C
    Arthritis Rheum; 2004 Aug; 50(8):2685-94. PubMed ID: 15334485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporomandibular joint damage in K/BxN arthritic mice.
    Kuchler-Bopp S; Mariotte A; Strub M; Po C; De Cauwer A; Schulz G; Van Bellinghen X; Fioretti F; Clauss F; Georgel P; Benkirane-Jessel N; Bornert F
    Int J Oral Sci; 2020 Feb; 12(1):5. PubMed ID: 32024813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-terminal kinase pathway.
    Lee SI; Boyle DL; Berdeja A; Firestein GS
    Arthritis Res Ther; 2012 Feb; 14(1):R38. PubMed ID: 22353730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-2α-induced chemokines stimulate motility of fibroblast-like synoviocytes and chondrocytes into the cartilage-pannus interface in experimental rheumatoid arthritis mouse models.
    Huh YH; Lee G; Lee KB; Koh JT; Chun JS; Ryu JH
    Arthritis Res Ther; 2015 Oct; 17():302. PubMed ID: 26510617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
    Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.
    Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Di Padova FE; Boots AM; Gram H; Joosten LA; van den Berg WB
    Am J Pathol; 2005 Jul; 167(1):141-9. PubMed ID: 15972960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits.
    Wang X; Liang J; Koike T; Sun H; Ichikawa T; Kitajima S; Morimoto M; Shikama H; Watanabe T; Sasaguri Y; Fan J
    Am J Pathol; 2004 Oct; 165(4):1375-83. PubMed ID: 15466401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency.
    Martin P; Talabot-Ayer D; Seemayer CA; Vigne S; Lamacchia C; Rodriguez E; Finckh A; Smith DE; Gabay C; Palmer G
    Arthritis Res Ther; 2013 Jan; 15(1):R13. PubMed ID: 23324173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deficiency of Wnt5a diminishes disease severity in a murine model of rheumatoid arthritis.
    MacLauchlan S; Zuriaga MA; Fuster JJ; Cuda CM; Jonason J; Behzadi F; Duffen JP; Haines GK; Aprahamian T; Perlman H; Walsh K
    Arthritis Res Ther; 2017 Jul; 19(1):166. PubMed ID: 28724439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cartilage damage and bone erosion are more prominent determinants of functional impairment in longstanding experimental arthritis than synovial inflammation.
    Hayer S; Bauer G; Willburger M; Sinn K; Alasti F; Plasenzotti R; Shvets T; Niederreiter B; Aschauer C; Steiner G; Podesser BK; Smolen JS; Redlich K
    Dis Model Mech; 2016 Nov; 9(11):1329-1338. PubMed ID: 27638666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of synovitis and joint destruction by a new single domain antibody specific for cyclophilin A in two different mouse models of rheumatoid arthritis.
    Wang L; Jia J; Wang C; Ma X; Liao C; Fu Z; Wang B; Yang X; Zhu P; Li Y; Chen Z
    Arthritis Res Ther; 2013; 15(6):R208. PubMed ID: 24314202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.
    Geven EJ; van den Bosch MH; Di Ceglie I; Ascone G; Abdollahi-Roodsaz S; Sloetjes AW; Hermann S; Schäfers M; van de Loo FA; van der Kraan PM; Koenders MI; Foell D; Roth J; Vogl T; van Lent PL
    Arthritis Res Ther; 2016 Oct; 18(1):247. PubMed ID: 27776554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice.
    Lamacchia C; Rodriguez E; Palmer G; Vigne S; Martin P; Talabot-Ayer D; Seemayer CA; Gabay C
    Ann Rheum Dis; 2012 Feb; 71(2):281-7. PubMed ID: 22072017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme oxygenase-1 regulates the progression of K/BxN serum transfer arthritis.
    Brines R; Maicas N; Ferrándiz ML; Loboda A; Jozkowicz A; Dulak J; Alcaraz MJ
    PLoS One; 2012; 7(12):e52435. PubMed ID: 23285041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models.
    De Nardo CM; Lenzo JC; Pobjoy J; Hamilton JA; Cook AD
    Arthritis Res Ther; 2010; 12(5):R199. PubMed ID: 20973954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The loss of α2β1 integrin suppresses joint inflammation and cartilage destruction in mouse models of rheumatoid arthritis.
    Peters MA; Wendholt D; Strietholt S; Frank S; Pundt N; Korb-Pap A; Joosten LA; van den Berg WB; Kollias G; Eckes B; Pap T
    Arthritis Rheum; 2012 May; 64(5):1359-68. PubMed ID: 22083543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis.
    Orosa B; García S; Martínez P; González A; Gómez-Reino JJ; Conde C
    Ann Rheum Dis; 2014 Jan; 73(1):298-305. PubMed ID: 23486415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.